NovaBridge Biosciences NBP
NASDAQ NBP
$1.34 -0.02 (-1.83%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Cash from Financing Activities (2019 - 2025)

Updated

NovaBridge Biosciences' Cash from Financing Activities was -$60.75 million in Q4 2025, compared with -$3.84 million a year earlier.

Analysis

NovaBridge Biosciences (NBP) Cash from Financing Activities (2019 - 2025) Analysis & Trends

On a trailing twelve-month basis, NovaBridge Biosciences' Cash from Financing Activities was -$3.84 million through Dec 31, 2025; for FY2024, it came in at -$4.17 million.

  • In earlier years, Cash from Financing Activities was $9.91 million in FY2023 (+253.3%), $2.81 million in FY2022 (-97.0%), $93.2 million in FY2021 (-82.3%) and $527.28 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 NovaBridge Biosciences 150.88 Mn 150.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -60.75 Mn
Sep 30, 2025 60.75 Mn
Dec 31, 2024 -3.84 Mn
Dec 31, 2020 127.47 Mn
Sep 30, 2020 280.56 Mn
Dec 31, 2019 16.07 Mn
API Access

NovaBridge Biosciences Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NBP&period=max&api_key=YOUR_API_KEY